MedPath

The effect of saffron in patients with mild cognitive impairment

Phase 2
Conditions
Mild cognitive impairment.
Mild cognitive impairment, so stated
G31.84
Registration Number
IRCT20090117001556N148
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Rey-AVLT<=8
Radiological Criteria: Bilateral Hippocampal volume <= ?.??cc
Radiological Criteria: Entorhinal cortex thinking <=?.?? m

Exclusion Criteria

The presence of an uncontrolled acute or chronic physical illness or a marked disturbance in the patient's tests
The presence of any neurological disease that leads to cognitive disorders, such as epilepsy or developmental and neurometabolic disorders and brain system inflammations
History of moderate and severe head trauma
Uncontrolled acute or chronic psychiatric illness including psychosis or mood disorder and severe depression
Any history of drug or alcohol abuse
Severe visual or motor impairment that prevents the implementation of the virtual reality navigation test
The presence of any contraindications to MRI during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of mild cognitive impairment. Timepoint: Weeks 0, 6, 12. Method of measurement: By Rey AVLT ? (MoCA (Montreal Cognitive Assessment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath